PD-1 remodels SHP2 dynamics and drives the non-catalytic inhibition of T cell activation
Panyu Fei(Zhejiang University), Wei Chen(Second Affiliated Hospital of Zhejiang University), Yu Zhang(Institute of Biophysics), Peng Jiao(Zhejiang Chinese Medical University), Peng Wu(Second Affiliated Hospital of Zhejiang University), Michael L. Dustin(Chinese Academy of Medical Sciences & Peking Union Medical College), Jizhong Lou(Institute of Biophysics), Lu Chen(Sir Run Run Shaw Hospital), Jie Gao(Second Affiliated Hospital of Zhejiang University), Hui Chen(Institute of Biophysics), Chun Zhou(Guangdong Pharmaceutical University), Lina Chen(Sir Run Run Shaw Hospital), Salvatore Valvo(University of Oxford)
Cited by 0
Related Papers
Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target
|Cancer Research|2005|467
CXCR4 Regulates Interneuron Migration in the Developing Neocortex
|Journal of Neuroscience|2003|455
Mechano-regulation of Peptide-MHC Class I Conformations Determines TCR Antigen Recognition
|Molecular Cell|2019|169
Highly efficient photocatalytic degradation of norfloxacin via Bi2Sn2O7/PDIH Z-scheme heterojunction: Influence and mechanism
|Journal of Hazardous Materials|2022|148
FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas
|Journal of Biological Chemistry|2013|134